Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,785
datasets available to search
ShareScore release 0.9.0
Dataset results
2,785 results for “genotyping”
Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
ClinicalTrials.gov study NCT02624063. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
ClinicalTrials.gov study NCT05516784. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4
ClinicalTrials.gov study NCT02405013. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)
ClinicalTrials.gov study NCT01761786. IPD Sharing: Not stated. Countries: 3. Publications: 15.
Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Riba
ClinicalTrials.gov study NCT00641654. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
ClinicalTrials.gov study NCT01323244. IPD Sharing: Not stated. Countries: 22. Publications: 1.
SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.
ClinicalTrials.gov study NCT00412334. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genotype Information and Functional Testing Study
ClinicalTrials.gov study NCT00992420. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genotypic Influences on Network Progression in Parkinson's Disease
ClinicalTrials.gov study NCT04228172. IPD Sharing: NO. Countries: 1. Publications: 20.
Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition
ClinicalTrials.gov study NCT03245749. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (
ClinicalTrials.gov study NCT02332720. IPD Sharing: YES. Countries: 0. Publications: 2.
Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial
ClinicalTrials.gov study NCT00211692. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants
ClinicalTrials.gov study NCT04387539. IPD Sharing: NO. Countries: 1. Publications: 1.
Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)
ClinicalTrials.gov study NCT00265395. IPD Sharing: YES. Countries: 0. Publications: 1.
Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLET
ClinicalTrials.gov study NCT00845065. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
ClinicalTrials.gov study NCT02582632. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
ClinicalTrials.gov study NCT01712906. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B
ClinicalTrials.gov study NCT06289725. IPD Sharing: NO. Countries: 1. Publications: 3.
Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss
ClinicalTrials.gov study NCT02130791. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients
ClinicalTrials.gov study NCT00801255. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.